Solutions to improve treatment Current immunosuppressors suppress the entire immune system leaving patients more vulnerable to everyday infections and higher rates of cancer However this is necessary because the immune system attacks parts of the body which are work well and are nee ID: 585488
Download Presentation The PPT/PDF document "Suppressing the immune system" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Suppressing the immune system
Solutions to improve treatmentSlide2
Current
immunosuppressors…
…suppress the entire immune system, leaving patients more vulnerable to everyday infections and higher rates of cancer.
However, this is necessary because the immune system attacks parts of the body which are work well and are needed (in MS, myelin is targeted, causing demyelination) but we cannot isolate the suppression to just one impact of the immune system so to protect the targeted area we must lower the guard of everywhere else. Slide3
What’s the better solution?
STEP
1:
Take white blood cells from the person with MS and insert large quantities of myelin antigens into them. Then inject them back into the patient.
STEP
2:
The cells then enter the spleen, which filters the blood and helps remove old and dying blood cells. During this process immune cells learn to recognise the myelin antigen as harmless because in the spleen, the particles are engulfed by macrophages (white blood cells that engulf pathogens and unwanted materials , then send signals to other immune cells to target those materials) so they are recognised as ordinary dying blood cells by the immune system.
Macrophage from the bloodSlide4
The effect
This creates immune tolerance to the myelin antigen and directly inhibits the myelin responsive T cells that attack them.
It also has the advantage of achieving this protection without altering or suppressing the function of the rest of the immune system.
The results of the phase 1 trial show the treatment to be safe and well tolerated. It reduced immune system reactivity to myelin by 50-75% and prevented future relapses in mice for up to 100 days, which is the equivalent of several years in the life of an MS patient.Slide5
Our ideas to further these effects
Simply attach the appropriate set of antigens to the white blood cells to help treat different autoimmune diseases!
Using a patient's white blood cells
to transport the myelin antigens to the spleen is
expensive
and
labour-intensive so we thought nanoparticles might be a cheaper and more accessible option. A useful nanoparticle could be from a polymer called PLG (Poly(Lactide-co-Glycolide)) because:It is made up of lactic and
glycolic acid, both of which found in the human body, so is unlikely to be rejected or attacked as a pathogen. It is biodegradable and will be dissolved naturally by the body.It is already approved by the US Food and Drug Administration (FDA) for other uses so it will not have detrimental side effects and the testing process will probably be accelerated.